
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Gastroenterol Hepatol Bed Bench</journal-id><journal-id journal-id-type="iso-abbrev">Gastroenterol Hepatol Bed Bench</journal-id><journal-id journal-id-type="publisher-id">GHFBB</journal-id><journal-title-group><journal-title>Gastroenterology and Hepatology From Bed to Bench</journal-title></journal-title-group><issn pub-type="ppub">2008-2258</issn><issn pub-type="epub">2008-4234</issn><publisher><publisher-name>Shaheed Beheshti University of Medical Sciences</publisher-name><publisher-loc>Tehran, Iran</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">32190228</article-id><article-id pub-id-type="pmc">7069536</article-id><article-id pub-id-type="publisher-id">GHFBB-13-77</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Frequency and molecular epidemiology of class A ESBLs producing Enteroinvasive <italic>Escherichia coli</italic> (EIEC) isolates among patients with diarrhea </article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Farajzadeh-Sheikh</surname><given-names>Ahmad</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Savari</surname><given-names>Mohammad</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Hosseini Nave</surname><given-names>Hossein</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Ahmadi Ahmadi</surname><given-names>Khadijeh</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Afzali</surname><given-names>Maryam</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>
<italic>Department of Microbiology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</italic>
</aff><aff id="aff2">
<label>2</label>
<italic> Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</italic>
</aff><aff id="aff3">
<label>3</label>
<italic>Department of Microbiology and Virology, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran</italic>
</aff><author-notes><corresp id="cor">Reprint or Correspondence: Maryam Afzali, PhD. Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. E-mail: maryamafzali1398@gmail.com</corresp></author-notes><pub-date pub-type="ppub"><season>Winter</season><year>2020</year></pub-date><volume>13</volume><issue>1</issue><fpage>77</fpage><lpage>85</lpage><history><date date-type="received"><day>15</day><month>10</month><year>2019</year></date><date date-type="accepted"><day>18</day><month>12</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9;2020 RIGLD, Research Institute for Gastroenterology and Liver Diseases </copyright-statement><license license-type="open-access"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Aim:</title><p>This study aimed to investigate the frequency and molecular epidemiology of class A ESBLs producing Enteroinvasive <italic>Escherichia coli</italic> (EIEC) isolates among patients with diarrhea.</p></sec><sec><title>Background:</title><p>Antibiotic resistance is widespread among diarrheagenic <italic>Escherichia coli</italic> (DEC) in developing countries. Information regarding Extended-Spectrum &#x003b2;-Lactamases (ESBLs) in diarrheagenic pathogens should be considered in clinical management when an optimal treatment is required.</p></sec><sec><title>Methods:</title><p>A total of 581 stool samples were collected from patients with diarrhea in Ahvaz, Iran. PCR was used for the presence of the<italic> ipaH </italic>gene to confirm EIEC strains. The antibiotic resistance pattern of all EIEC isolates was determined by the disk diffusion method. EIEC isolates were screened for class A &#x003b2;-lactamase genes. Genotyping of harboring &#x003b2;-lactamase genes was performed by Multi-Locus VNTR Analysis (MLVA). </p></sec><sec><title>Results:</title><p>Among 13 EIEC isolates, 9 isolates (69.2%) were found ESBL positive by double-disk synergy test (DDST) and PCR. Furthermore, <italic>bla</italic><sub>CTX-M-15</sub> and <italic>bla</italic><sub>CTX-M-1</sub> genes were detected in 77.8% (n=7) and 44.5% (n=4) of the <italic>bla</italic><sub>CTX-M-1</sub> group. On the other hand, the <italic>bla</italic><sub>TEM-1</sub> gene was detected in 66.6% (n=6). None of the isolates had <italic>bla</italic><sub>SHV-1</sub>, <italic>bla</italic><sub>KPC</sub>, or <italic>bla</italic><sub>GES</sub> genes. Six MLVA genotypes were identified. </p></sec><sec><title>Conclusion:</title><p>The current study revealed that the presence of ESBLs genes mediates the resistance of EIEC isolates to the majority of antibiotics in this region. The presence of ESBLs genes in different MLVA types showed that one specific clone was not responsible for spreading the EIEC isolates.</p></sec></abstract><kwd-group><title>Key Words</title><kwd>Enteroinvasive Escherichia coli</kwd><kwd>Diarrhea</kwd><kwd>ESBLs</kwd><kwd>MLVA</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p> Severe gastroenteritis results in approximately 800,000 deaths annually by some bacteria. Among the bacterial pathogens, diarrheagenic <italic>Escherichia coli </italic>(DEC) is the most frequent (<xref rid="B1" ref-type="bibr">1</xref>). Enteroinvasive Escherichia coli (EIEC) is one of the pathotypes of DEC which causes Shigella-like dysentery in both children and adults (<xref rid="B2" ref-type="bibr">2</xref>). EIEC, as with Shigella, can cause invasion and penetration to the epithelial cells of the colon, leading to dysentery, which is an important factor in the mortality of children in developing countries (<xref rid="B3" ref-type="bibr">3</xref>). Various genes are involved in the pathogenesis of EIEC strains. One of these genes is an invasive plasmid antigen (<italic>ipaH</italic>) gene which is a key virulence factor for EIEC strains (<xref rid="B4" ref-type="bibr">4</xref>). The <italic>ipaH</italic> gene is currently used to confirm EIEC, as the gene is present in multiple copies located on both chromosomes and the plasmid (<xref rid="B5" ref-type="bibr">5</xref>). Over the last decades, multidrug resistance (MDR) has increased among <italic>E. coli</italic> clinical isolates. MDR phenotype is obtained by many different mechanisms in clinical isolates. One of the major mechanisms that could lead to the spread of MDR phenotype is the production of extended-spectrum &#x003b2;-lactamase (ESBLs) (<xref rid="B6" ref-type="bibr">6</xref>). The spread of ESBLs is a global public health problem. ESBLs can develop resistance to antibiotics such as third and fourth-generation cephalosporins and monobactams (<xref rid="B7" ref-type="bibr">7</xref>). The &#x003b2;-lactamases are divided into four categories; A, B, C, and D, based on the Ambler classification. The CTX-M, TEM, SHV, GES, and KPC enzymes belong to class A. These enzymes are encoded by mobile genetic elements usually located on plasmids causing various types of ESBLs to spread globally (<xref rid="B8" ref-type="bibr">8</xref>). Among ESBLs, the CTX-M group has been reported globally, and CTX-M-15 is widely distributed around the world. KPC and GES enzymes can hydrolyze the carbapenems used for the treatment of MDR infections (<xref rid="B9" ref-type="bibr">9</xref>). The clonal distribution nature of strains harboring the ESBLs genes is a real problem and has been confirmed by many studies (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B11" ref-type="bibr">11</xref>). Genotyping methods provide useful information for generating genetic relationships among bacterial pathogens for epidemiological research and evolutionary studies. Multilocus variable-number tandem repeat analysis (MLVA) is a PCR-based typing technique used for distinguishing between bacterial isolates. In recent years, various studies have been conducted on Variable Number Tandem Repeat (VNTR) loci variations to discriminate different <italic>E. coli</italic> strains (<xref rid="B12" ref-type="bibr">12</xref>). According to previous studies, in comparison with other typing methods such as pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST), this method is a rapid and low-cost genotyping method which can differentiate closely related strains of bacteria from each other. The MLVA also allowed us to establish associations between genotypes and parameters such as ESBLs genes and multidrug-resistant (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B12" ref-type="bibr">12</xref>). Although EIEC is an important etiologic agent of diarrhea in different parts of the world, very few reports are available about the occurrence of ESBLs among them and there is no information about the genetic diversity of EIEC strains harboring &#x003b2;-lactamase genes in Iran. Since the clonal circulation of the EIEC strains in our hospital is unclear, thus, this study aimed to investigate the frequency and molecular epidemiology of class A ESBLs producing EIEC isolates among patients with diarrhea. </p></sec><sec sec-type="methods"><title>Methods</title><p>
<bold>Ethical statement </bold>
</p><p>This study was approved by the Ethics Committee of Ahvaz Jundishapur University of Medical Sciences (IR.AJUMS.REC.1396.434), Ahvaz, Iran.</p><p>
<bold>Bacterial isolates</bold>
</p><p>In this cross-sectional study and using the Cochran formula, 581 stool samples were collected from patients with diarrhea referring to the teaching hospitals (Golestan and Abouzar hospitals), in Ahvaz, Iran, from September 2016 to August 2017. Patients with a history of fever, vomiting, nausea, abdominal cramps, watery and bloody diarrhea were included in our study. Also, they had not used the antibiotic nearly 2 weeks before. If patients had taken antibiotics in the last two weeks, they would be excluded from our study.</p><p>Stool samples were initially cultured on Hektoen enteric agar and MacConkey agar (Merck, Germany). After overnight incubation at 37&#x000b0;<sup>C</sup>, lactose positive colonies were tested by standard biochemical and bacteriological tests such as Triple Sugar Iron agar (TSI), Christensen&#x02019;s urea agar, Indole test, Methyl red and Voges-Proskauer tests, and Simmons citrate agar (Merck, Germany) for detection of <italic>E. coli </italic>isolates (<xref rid="B3" ref-type="bibr">3</xref>). All isolates confirmed as <italic>E. coli</italic> were preserved in Tryptic Soy Broth (TSB) (Merck, Germany), containing glycerol (30%) at -70&#x000b0;<sup>C</sup>.</p><p>
<bold>Molecular confirmation of EIEC strains</bold>
</p><p>All <italic>E. coli</italic> isolates were confirmed as EIEC through amplifying the <italic>ipaH</italic> gene (<xref rid="B4" ref-type="bibr">4</xref>). DNA extraction of <italic>E. coli</italic> isolates was performed by the boiling method previously described (<xref rid="B11" ref-type="bibr">11</xref>). The sequences of primers used for the detection of the <italic>ipaH</italic> gene are shown in <xref rid="T1" ref-type="table">Table 1</xref>. Regarding the volume, the reaction was performed in a final volume of 25 &#x003bc;l containing 1X PCR buffer, 1U Taq polymerase, 1 &#x003bc;M MgCl<sub>2</sub>, 200 &#x003bc;M of dNTP (CinnaGen, Iran), 0.2 &#x003bc;l of each primer, and 3 &#x003bc;l of DNA template. The amplification reaction was programmed by a thermal cycler (Eppendorf, Germany) as follows: Initial denaturation at 94 &#x000b0;C for 5 min, 35 cycles of 94 &#x000b0;C for 30 s, annealing 61&#x000b0;C for 45 s, extension 72&#x000b0;C for 1min and final extension 72&#x000b0;C for 5 min. The PCR products were separated on a 1.5% agarose gel containing ethidium bromide and finally visualized in the gel documentation system (Protein simple, USA). <italic>Shigella flexnery</italic> ATCC 12122 was used as a positive PCR control for the <italic>ipaH</italic> gene.</p><p>
<bold>Antibiotic susceptibility testing</bold>
</p><p>Antibiotic susceptibility testing was performed on all EIEC isolates tested by the Kirby-Bauer disk diffusion method on Muller-Hinton agar medium (Merck, Germany), based on the Clinical and Laboratory Standard Institute (CLSI) guidelines 2018 (<xref rid="B13" ref-type="bibr">13</xref>). The antibiotics included cefotaxime (30 &#x003bc;g), ceftriaxone (30 &#x003bc;g), ceftazidime (30 &#x003bc;g), amikacin (30 &#x003bc;g), imipenem (10 &#x003bc;g), ciprofloxacin (5 &#x003bc;g), colistin sulfate (10 &#x003bc;g), gentamicin (10 &#x003bc;g), aztreonam (30 &#x003bc;g), Sulfamethoxazole-trimethoprim (25 &#x003bc;g), and tetracycline (30 &#x003bc;g) (Mast, UK). <italic>E. coli</italic> ATCC 25922 strain was used as quality control. The phenotype of EIEC was defined as MDR according to the International Expert proposal for Interim Standards Guidelines (<xref rid="B14" ref-type="bibr">14</xref>).</p><p>
<bold>Phenotypic detection of carbapenemase </bold>
</p><p>Imipenem-resistant strains were screened for carbapenemase production using the modified Hodge test (MHT) (<xref rid="B13" ref-type="bibr">13</xref>).</p><p>
<bold>Phenotypic detection of ESBLs production</bold>
</p><p>DDST is recommended by CLSI for the phenotypic characterization of ESBL-producing isolates (<xref rid="B13" ref-type="bibr">13</xref>). All EIEC isolates were tested by combination disk tests with cefotaxime and ceftazidime (30 &#x003bc;g), with and without clavulanic acid (10 &#x003bc;g), as described by the CLSI guidelines 2018. According to that, a &#x02265; 5 mm increase in the inhibitory zone diameter for cefotaxime or ceftazidime in combination with clavulanic acid versus the zone diameter of the antimicrobial agent alone is defined as ESBL producer (<xref rid="B13" ref-type="bibr">13</xref>). <italic>Klebsiella pneumonia</italic> ATCC 700603 and <italic>E. coli</italic> ATCC 25922 were used as positive and negative controls, respectively. </p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Primers used in this study to detect <italic>ipaH</italic> and ESBLs genes</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="justify" rowspan="1" colspan="1">Gene</th><th align="justify" rowspan="1" colspan="1">Primer Sequence (5&#x000b4;-3&#x000b4;)</th><th align="center" rowspan="1" colspan="1">Amplicon Size (bp)</th><th align="center" rowspan="1" colspan="1">Annealing Temperature(&#x000b0;C)</th><th align="center" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="justify" rowspan="1" colspan="1">
<italic>ipaH</italic>
</td><td align="justify" rowspan="1" colspan="1">F-GAAAACCCTCCTGGTCCATCAGG<break/>R-GCCGGTCAGCCACCCTCTGAGAGTAC</td><td align="center" rowspan="1" colspan="1">437</td><td align="center" rowspan="1" colspan="1">61</td><td align="left" rowspan="1" colspan="1">
<xref rid="B4" ref-type="bibr">4</xref></td></tr><tr><td align="justify" rowspan="1" colspan="1">
<italic>bla</italic>
<sub>CTX-M-1</sub> Group</td><td align="left" rowspan="1" colspan="1">F-GGTTAAAAAATCACTGCGTC<break/>R-TTGGTGACGATTTTAGCCGC</td><td align="center" rowspan="1" colspan="1">863</td><td align="center" rowspan="1" colspan="1">54</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">
<italic>bla</italic>
<sub>CTXM-15</sub>
</td><td align="left" rowspan="1" colspan="1">F-CACACGTGGAATTTAGGGACT<break/>R-GCCGTCTAAGGCGATAAACA</td><td align="center" rowspan="1" colspan="1">995</td><td align="center" rowspan="1" colspan="1">55</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">
<italic>bla</italic>
<sub>CTX-M-1</sub>
</td><td align="left" rowspan="1" colspan="1">F-GGTTAAAAAATCACTGCGTC<break/>R-TTGGTGACGATTTTAGCCGC</td><td align="center" rowspan="1" colspan="1">850</td><td align="center" rowspan="1" colspan="1">60</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">
<italic>bla</italic>
<sub>TEM-1</sub>
</td><td align="justify" rowspan="1" colspan="1">F-GCTATGTGGCGCGGTATTAT<break/>R-AAGTTGGCCGCAGTGTTATC</td><td align="center" rowspan="1" colspan="1">189</td><td align="center" rowspan="1" colspan="1">56</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">
<italic>bla</italic>
<sub>SHV-1</sub>
</td><td align="justify" rowspan="1" colspan="1">F-CCTCATTCAGTTCCGTTTCC<break/>R-CCGCGTAGGCATGATAGAAA</td><td align="center" rowspan="1" colspan="1">389</td><td align="center" rowspan="1" colspan="1">56</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">
<italic>bla</italic>
<sub>KPC</sub>
</td><td align="left" rowspan="1" colspan="1">F-CGTCTAGTTCTGCTGTCTTG <break/>R-CTTGTCATCCTTGTTAGGCG</td><td align="center" rowspan="1" colspan="1">538</td><td align="center" rowspan="1" colspan="1">59</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">
<italic>bla</italic>
<sub>GES</sub>
</td><td align="left" rowspan="1" colspan="1">F-ATGCGCTTCATTCACGCAC<break/>R-CTATTTGTCCGTGCTCAGG</td><td align="center" rowspan="1" colspan="1">860</td><td align="center" rowspan="1" colspan="1">59</td><td align="left" rowspan="1" colspan="1"/></tr></tbody></table></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Locus-specific PCR primers selected for MLVA</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Locus</th><th align="left" rowspan="1" colspan="1">Primer Sequence</th><th align="center" rowspan="1" colspan="1">Repeat Size (bp)</th><th align="center" rowspan="1" colspan="1">AnnealingTemperature (&#x000b0;C)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<italic>ms06 </italic>
</td><td align="left" rowspan="1" colspan="1">F-AAACGGGAGAGCCGGTTATT<break/>R-TGTTGGTACAACGGCTCCTG</td><td align="center" rowspan="1" colspan="1">39</td><td align="center" rowspan="1" colspan="1">57</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>ms07</italic>
</td><td align="left" rowspan="1" colspan="1">F-GTCAGTTCGCCCAGACACAG<break/>R-CGGTGTCAGCAAATCCAGAG</td><td align="center" rowspan="1" colspan="1">39</td><td align="center" rowspan="1" colspan="1">57</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>ms09</italic>
</td><td align="left" rowspan="1" colspan="1">F-GTGCCATCGGGCAAAATTAG<break/>R-CCGATAAGGGAGCAGGCTAGT</td><td align="center" rowspan="1" colspan="1">179</td><td align="center" rowspan="1" colspan="1">57</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>ms11</italic>
</td><td align="left" rowspan="1" colspan="1">F-GAAACAGGCCCAGGCTACAC<break/>R-CTGGCGCTGGTTATGGGTAT</td><td align="center" rowspan="1" colspan="1">96</td><td align="center" rowspan="1" colspan="1">57</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>ms21</italic>
</td><td align="left" rowspan="1" colspan="1">F-GCTGATGGCGAAGGAGAAGA<break/>R-GGGAGTATGCGGTCAAAAGC</td><td align="center" rowspan="1" colspan="1">141</td><td align="center" rowspan="1" colspan="1">57</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>ms23</italic>
</td><td align="left" rowspan="1" colspan="1">F-GCTCCGCTGATTGACTCCTT<break/>R-CGGTTGCTCGACCACTAACA</td><td align="center" rowspan="1" colspan="1">375</td><td align="center" rowspan="1" colspan="1">57</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>ms32</italic>
</td><td align="left" rowspan="1" colspan="1">F-TGAGATTGCCGAAGTGTTGC <break/>R- AACTGGCGGCGTTTATCAAG </td><td align="center" rowspan="1" colspan="1">101</td><td align="center" rowspan="1" colspan="1">57</td></tr></tbody></table></table-wrap><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Distribution EIEC strains according to seasons, age, gender and clinical symptoms</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Strain ID</th><th align="left" rowspan="1" colspan="1">Sex</th><th align="left" rowspan="1" colspan="1">Age (month)</th><th align="left" rowspan="1" colspan="1">Seasonality</th><th align="left" rowspan="1" colspan="1">clinical symptoms</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">EIEC 1</td><td align="left" rowspan="1" colspan="1">Female</td><td align="left" rowspan="1" colspan="1">0-12</td><td align="left" rowspan="1" colspan="1">Spring</td><td align="left" rowspan="1" colspan="1">Watery stool, Abdominal pain, Vomiting</td></tr><tr><td align="left" rowspan="1" colspan="1">EIEC 2</td><td align="left" rowspan="1" colspan="1">
<inline-formula><mml:math id="M1"><mml:mi mathvariant="normal">Female</mml:mi></mml:math></inline-formula>
</td><td align="left" rowspan="1" colspan="1">0-12</td><td align="left" rowspan="1" colspan="1">Spring</td><td align="left" rowspan="1" colspan="1">Watery stool, Abdominal pain, Fever</td></tr><tr><td align="left" rowspan="1" colspan="1">EIEC 3</td><td align="left" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">0-12</td><td align="left" rowspan="1" colspan="1">Summer</td><td align="left" rowspan="1" colspan="1">Watery stool, Vomiting, , Fever</td></tr><tr><td align="left" rowspan="1" colspan="1">EIEC 4</td><td align="left" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">13-24</td><td align="left" rowspan="1" colspan="1">Summer</td><td align="left" rowspan="1" colspan="1">Watery stool, Abdominal pain,</td></tr><tr><td align="left" rowspan="1" colspan="1">EIEC 5</td><td align="left" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">0-12</td><td align="left" rowspan="1" colspan="1">Summer</td><td align="left" rowspan="1" colspan="1">Watery stool, Abdominal pain, Fever</td></tr><tr><td align="left" rowspan="1" colspan="1">EIEC 6</td><td align="left" rowspan="1" colspan="1">Female</td><td align="left" rowspan="1" colspan="1">49-60</td><td align="left" rowspan="1" colspan="1">Summer</td><td align="left" rowspan="1" colspan="1">Watery stool, Abdominal pain</td></tr><tr><td align="left" rowspan="1" colspan="1">EIEC 7</td><td align="left" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">0-12</td><td align="left" rowspan="1" colspan="1">Summer</td><td align="left" rowspan="1" colspan="1">Abdominal pain, Vomiting</td></tr><tr><td align="left" rowspan="1" colspan="1">EIEC 8</td><td align="left" rowspan="1" colspan="1">Female</td><td align="left" rowspan="1" colspan="1">0-12</td><td align="left" rowspan="1" colspan="1">Spring</td><td align="left" rowspan="1" colspan="1">Watery stool</td></tr><tr><td align="left" rowspan="1" colspan="1">EIEC 9</td><td align="left" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">13-24</td><td align="left" rowspan="1" colspan="1">Winter</td><td align="left" rowspan="1" colspan="1">Watery stool, Abdominal pain</td></tr><tr><td align="left" rowspan="1" colspan="1">EIEC 10</td><td align="left" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">0-12</td><td align="left" rowspan="1" colspan="1">Summer</td><td align="left" rowspan="1" colspan="1">Watery stool, Abdominal pain, Vomiting</td></tr><tr><td align="left" rowspan="1" colspan="1">EIEC 11</td><td align="left" rowspan="1" colspan="1">Female</td><td align="left" rowspan="1" colspan="1">49-60</td><td align="left" rowspan="1" colspan="1">Summer</td><td align="left" rowspan="1" colspan="1">Watery stool</td></tr><tr><td align="left" rowspan="1" colspan="1">EIEC 12<break/>EIEC 13</td><td align="left" rowspan="1" colspan="1">Male<break/>Male</td><td align="left" rowspan="1" colspan="1">13-24<break/>0-12</td><td align="left" rowspan="1" colspan="1">Winter<break/>Spring</td><td align="left" rowspan="1" colspan="1">Abdominal pain, Vomiting<break/>Watery stool, Fever</td></tr></tbody></table></table-wrap><p>
<bold>Molecular Detection of &#x003b2;-Lactamase Genes</bold>
</p><p>PCR was performed for detection of <italic>bla</italic><sub>CTX-M-1, </sub><italic>bla</italic><sub>CTXM-15, </sub><italic>bla</italic><sub>TEM-1</sub><italic>, bla</italic><sub>SHV-1</sub><italic>, bla</italic><sub>KPC, </sub>and <italic>bla</italic><sub>GES </sub>genes. The PCR conditions were similar to previous studies (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B15" ref-type="bibr">15</xref>-<xref rid="B17" ref-type="bibr">17</xref>). The specific primers and annealing temperatures of ESBLs genes are listed in <xref rid="T1" ref-type="table">Table 1</xref>.</p><p>
<bold>Genotyping of ESBLs producing EIEC isolates by MLVA analysis</bold>
</p><p>MLVA was performed for ESBLs genes-harboring EIEC isolates. Seven VNTR loci were selected for the genetic typing of the EIEC isolates. PCR was carried out as described by a previous study (<xref rid="B18" ref-type="bibr">18</xref>). The primers and repeat sizes for each locus are shown in <xref rid="T2" ref-type="table">Table 2</xref>. The PCR products were electrophoresed on a 1.5% agarose gel containing ethidium bromide and visualized in a gel documentation system (Protein simple, USA). The copy numbers of the repeat for each isolate were calculated by the following formula:</p><p>Number of repeats = size of each locus (bp) &#x02013; flanking regions (bp)/repeat size (bp).</p><p>The results were imported into Microsoft Excel 2010 software and analyzed by the Bionumerics Software v.6.6 (Applied maths, Sint-Martens-Latem, Belgium). For clustering, a cut-off value of 90% similarity was used. The dendrogram of genetic relationships was generated using the Unweighted Pair Group Method with Average linkages (UPGMA) (<xref rid="B19" ref-type="bibr">19</xref>).</p><p>
<bold>Statistical analysis</bold>
</p><p>The results were analyzed, using SPSS version 16 to obtain frequencies and comparisons among clones. A nonparametric chi-square test was also applied. A P.value of &#x0003c; 0.05 was considered statistically significant. </p></sec><sec sec-type="results"><title>Results</title><p>
<bold>Study population</bold>
</p><p>In this descriptive cross-sectional study, 581 stool samples were collected from patients with diarrhea from two teaching hospitals including Golestan and Abouzar hospitals in Ahvaz, Iran. The patients&#x02019; age ranged between 0 and 81 years. Out of 581 diarrhea samples, 43.2% (n=251) were DEC strains confirmed by culture and biochemical tests. </p><p>
<bold>Distribution of E. coli and EIEC </bold>
</p><p>Of the 251 DEC, 57.4% (n=144) were isolated from the children and 42.6% (n=107) from adults. The occurrence of DEC strains in males and females was 54.6% (n=137) and 45.4% (n=114), respectively. Of the 144 children, 54.9% (n=79) were male and 45.1% (n=65) were female, and among the 107 adults, 54.2% (n=58) were male and 45.8% (n=49) were female. Out of 251 <italic>E.coli</italic> isolates, 5.1% (n=13) were positive for<italic> ipaH</italic>. All the EIEC strains were retrieved from children. Of 13 strains of EIEC, 84.6% (n=11) isolated from children under the age of 2 years (P&#x0003c;0.05). The distribution of EIEC strains according to age, gender, and clinical symptoms is shown in <xref rid="T3" ref-type="table">Table 3</xref>.</p><p>
<bold>Antimicrobial susceptibility test of EIEC strains </bold>
</p><p>Among 13 EIEC isolates, all isolates were susceptible to ciprofloxacin. The highest rate of antibiotics resistance was found against ampicillin 100% (n=13), followed by trimethoprim/sulfamethoxazole 84.6% (n=11), tetracycline 76.9% (n=10) (<xref rid="T4" ref-type="table">Table 4</xref>). The MDR phenotype was observed in 76.9% (n=10) of the EIEC isolates. MHT results for two imipenem-resistant isolates showed that both strains were positive for carbapenemase phenotype. The results of antimicrobial susceptibility testing of the 13 EIEC isolates to 12 antibiotics are summarized in <xref rid="T4" ref-type="table">Table 4</xref>. Our data revealed nine phenotypic patterns of resistance among EIEC isolates (<xref rid="T5" ref-type="table">Table 5</xref>).</p><p>
<bold>Phenotypic ESBLs detection</bold>
</p><p> Out of 13 EIEC, 69.2% (n=9) isolates were ESBLs producers when tested by the DDST. All EIEC isolates that were positive for ESBLs revealed the MDR phenotypes.</p><p>
<bold>Detection of &#x003b2;-lactamase genes</bold>
</p><p>PCR was performed for all EIEC strains. Of 9 ESBL producers, 77.8% (n=7) strains carried the <italic>bla</italic><sub>CTX-M-1</sub> group. The <italic>bla</italic><sub>CTX-M-15</sub> subtype was identified in all of the <italic>bla</italic><sub>CTX-M-1</sub> groups while the <italic>bla</italic><sub>CTX-M-1</sub> variant was detected in 44.5% (n=4) isolates of the <italic>bla</italic><sub>CTX-M-1</sub> group. On the other hand, the <italic>bla</italic><sub>TEM-1</sub> gene was detected in 66.6% (n=6). None of the isolates had <italic>bla</italic><sub>SHV-1</sub>, <italic>bla</italic><sub>KPC</sub>, and <italic>bla</italic><sub>GES</sub> genes. The <italic>bla</italic><sub>TEM-1</sub> and <italic>bla</italic><sub>CTX-M-1</sub> genes were found to coexist with <italic>bla</italic><sub>CTX-M-15</sub> in 4 isolates.</p><p>
<bold>MLVA assay</bold>
</p><p>Analysis of the MLVA profiles using UPGMA showed that nine EIEC ESBL producers isolates were grouped into six distinct MLVA types with two clusters and three singletons, and three multitone genotypes (<xref ref-type="fig" rid="F1">Figure1</xref>). All MLVA- Loci were present in all studied isolates. The minimal spanning tree (MST) of virulence genes distribution among different MLVA patterns is shown in <xref ref-type="fig" rid="F2">Figure 2</xref>. Each circle denotes an MLVA type, with the number of isolates in each type, as indicated within the circle.</p><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>The antibiotic susceptibility testing results of EIEC isolates</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Antimicrobial</th><th align="center" rowspan="1" colspan="1">Susceptible</th><th align="center" rowspan="1" colspan="1">Resistant</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Cefotaxime</td><td align="center" rowspan="1" colspan="1">4 (30.7%)</td><td align="center" rowspan="1" colspan="1">9 (69%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Ceftriaxone</td><td align="center" rowspan="1" colspan="1">4 (30.7%)</td><td align="center" rowspan="1" colspan="1">9 (69%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Ceftazidime</td><td align="center" rowspan="1" colspan="1">6 (46.1%)</td><td align="center" rowspan="1" colspan="1">7 (53.8%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Imipenem</td><td align="center" rowspan="1" colspan="1">11 (84.6%)</td><td align="center" rowspan="1" colspan="1">2 (15.3%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Ciprofloxacin</td><td align="center" rowspan="1" colspan="1">13 (100%)</td><td align="center" rowspan="1" colspan="1">0 (0%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Tetracycline</td><td align="center" rowspan="1" colspan="1">3 (23%)</td><td align="center" rowspan="1" colspan="1">10 (76.9%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Trimethoprim/Sulfamethoxazole</td><td align="center" rowspan="1" colspan="1">2 (15.3%)</td><td align="center" rowspan="1" colspan="1">11 (84.6%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Gentamicin</td><td align="center" rowspan="1" colspan="1">6 (46.1%)</td><td align="center" rowspan="1" colspan="1">7 (53.8%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Amikacin</td><td align="center" rowspan="1" colspan="1">10 (76.9%)</td><td align="center" rowspan="1" colspan="1">3 (23%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Ampicillin</td><td align="center" rowspan="1" colspan="1">0 (0%)</td><td align="center" rowspan="1" colspan="1">13 (100%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Aztreonam</td><td align="center" rowspan="1" colspan="1">8 (61.5%)</td><td align="center" rowspan="1" colspan="1">5 (38.4%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Colistin sulfate</td><td align="center" rowspan="1" colspan="1">12 (92.3%)</td><td align="center" rowspan="1" colspan="1">1 (7.6%)</td></tr></tbody></table></table-wrap><table-wrap id="T5" position="float"><label>Table 5</label><caption><p>Antibiotic resistance phenotypic patterns of EIEC isolates</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Resistance Pattern</th><th align="left" rowspan="1" colspan="1">Phenotypic resistance</th><th align="center" rowspan="1" colspan="1">Number of resistant EIEC isolates (%)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">I</td><td align="left" rowspan="1" colspan="1">
<italic>AMP</italic>
</td><td align="center" rowspan="1" colspan="1">2 (15.3%)</td></tr><tr><td align="left" rowspan="1" colspan="1">II</td><td align="left" rowspan="1" colspan="1">AMP, SXT</td><td align="center" rowspan="1" colspan="1">1 (7.6%)</td></tr><tr><td align="left" rowspan="1" colspan="1">III</td><td align="left" rowspan="1" colspan="1">AMP, SXT, TET</td><td align="center" rowspan="1" colspan="1">1 (7.6%)</td></tr><tr><td align="left" rowspan="1" colspan="1">IV </td><td align="left" rowspan="1" colspan="1">AMP, SXT, TET, CTX, CRO, GM</td><td align="center" rowspan="1" colspan="1">2 (15.3%)</td></tr><tr><td align="left" rowspan="1" colspan="1">V</td><td align="left" rowspan="1" colspan="1">AMP, SXT, TET, CTX, CRO, CAZ, GM</td><td align="center" rowspan="1" colspan="1">1 (7.6%)</td></tr><tr><td align="left" rowspan="1" colspan="1">VI</td><td align="left" rowspan="1" colspan="1">AMP, SXT, TET, CTX, CRO, CAZ, GM, CO</td><td align="center" rowspan="1" colspan="1">1 (7.6%)</td></tr><tr><td align="left" rowspan="1" colspan="1">VII</td><td align="left" rowspan="1" colspan="1">AMP, SXT, TET, CTX, CRO, CAZ, ATM, AK</td><td align="center" rowspan="1" colspan="1">2 (15.3%)</td></tr><tr><td align="left" rowspan="1" colspan="1">VIII</td><td align="left" rowspan="1" colspan="1">AMP, SXT, TET, CTX, CRO, CAZ, ATM, GM, AK</td><td align="center" rowspan="1" colspan="1">1 (7.6%)</td></tr><tr><td align="left" rowspan="1" colspan="1">IX</td><td align="left" rowspan="1" colspan="1">AMP, SXT, TET, CTX, CRO, CAZ, ATM, GM, IMP</td><td align="center" rowspan="1" colspan="1">2 (15.3%)</td></tr></tbody></table><table-wrap-foot><p>CTX: cefotaxime, CRO: ceftriaxone, CAZ: ceftazidime, AK: amikacin , IMP: imipenem, CO:colistin sulfate, GM: gentamicin, ATM: aztreonam, SXT: Sulfamethoxazole-trimethoprim, TET: tetracycline, AMP: ampicillin</p></table-wrap-foot></table-wrap><fig id="F1" position="float"><label>Figure 1</label><caption><p>Dendrogram representing the genetic diversity of nine ESBL producer-EIEC Isolates by MLVA; class A &#x003b2;-lactamase genes; Antibiotic resistance patterns</p></caption><graphic xlink:href="GHFBB-13-77-g001"/></fig></sec><sec sec-type="discussion"><title>Discussion</title><p>EIEC is one of the causes of childhood diarrhea in our country. Unfortunately, there are limited reports on the prevalence of EIEC in Iran. Due to the inability of conventional culture methods to detect pathogenic E. coli from non-pathogenic isolates, EIEC is usually ignored (<xref rid="B3" ref-type="bibr">3</xref>). Our results showed that 5.1% (n=13) of the DEC isolates were EIEC.</p><fig id="F2" position="float"><label>Figure 2</label><caption><p>Minimal Spanning Tree of 9 ESBL producer-EIEC Isolates. Categorical coefficient was used to construct the MST, showing the distances and the genetic relationships between the ESBLs genes-harboring EIEC isolates</p></caption><graphic xlink:href="GHFBB-13-77-g002"/></fig><p>This is higher than prevalence rates mentioned in similar reports from Northern Iran (0.5%) (<xref rid="B20" ref-type="bibr">20</xref>), south of Iran (4.9%) (<xref rid="B21" ref-type="bibr">21</xref>), as well as lower than those mentioned in a report from Shiraz (14.3%) (<xref rid="B3" ref-type="bibr">3</xref>). It seems that the different distribution of EIEC strains in various studies is due to the difference in geographic and socioeconomic variables, laboratory mistakes in identifying isolates, time, and study conditions. Most studies have been performed in children under the age of 5 (<xref rid="B21" ref-type="bibr">21</xref>-<xref rid="B23" ref-type="bibr">23</xref>). In our study, there was no age limit for sample collection, but all EIEC isolates were detected in children. Given the importance of this invasive pathogen, further studies should be focused on why EIEC is prevalent in children in this region. As with our study, Natarajan et al. in India, identified EIEC strains only in children (<xref rid="B24" ref-type="bibr">24</xref>). We showed that most of the EIEC strains were isolated from children are under age of 2. Previous studies have also indicated that EIEC is more common in children under 2 years (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B22" ref-type="bibr">22</xref>), which is similar to our study.</p><p>According to the WHO guidelines, antibiotics should not be used regularly for the treatment of diarrhea, especially for unknown causes. Antibiotics should be used in bloody and chronic diarrhea to reduce the duration of the disease and the selection of effective antibiotics for the treatment of the patient is necessary (<xref rid="B25" ref-type="bibr">25</xref>). However, antimicrobials are widely used to treat diarrhea in Iran. In the present study, the antimicrobial susceptibility pattern showed that ciprofloxacin had the most effect on EIEC isolates. Nevertheless, ciprofloxacin and other quinolones are not used for children because of the risk of damage to immature joints.</p><p>The results of this study revealed that the &#x003b2;-lactams, ampicillin, gentamicin, tetracycline, and trimethoprim/ sulfamethoxazole antibiotics had the minimum activity on EIEC strains. Resistance to these antibiotics was more than 50%. These results are consistent with previous reports (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B26" ref-type="bibr">26</xref>). The extent of EIEC resistance to first-line drugs such as ampicillin, trimethoprim/sulfamethoxazole, and tetracycline in our study may be based on the misuse and overuse of these antibiotics for the treatment of diarrhea. This may result in the spread of antibiotic-resistant bacteria (<xref rid="B27" ref-type="bibr">27</xref>). </p><p>Resistance to some broad-spectrum antibiotics such as colistin, ciprofloxacin, imipenem, and amikacin is limited and can be used to treat MDR diarrheal diseases. In this study, the MDR rates of EIEC strains were evaluated. Our results indicated that MDR rates were higher than in a previous study in Ahvaz (<xref rid="B23" ref-type="bibr">23</xref>). It seems that misuse and overuse of antibiotics for the treatment of diarrhea is one of the main causes of high levels of MDR in Ahvaz. The spread of ESBLs is a global health problem. ESBL production is one of the main mechanisms that can spread MDR (<xref rid="B17" ref-type="bibr">17</xref>). In our study, the prevalence of ESBLs positive in EIEC isolates was (69.2%), which was lower than another study in Ahaz (83%) (<xref rid="B23" ref-type="bibr">23</xref>), but higher than a study in Shiraz (50%) (<xref rid="B26" ref-type="bibr">26</xref>). In the last decade, the <italic>bla</italic><sub>CTX-M</sub> has been the most common ESBLs among MDR organisms around the world. The <italic>bla</italic><sub>CTX-M</sub> genes are effective against cefotaxime. Within the CTX-M-1 group, CTX-M-15 is the most widely disseminated genotype (<xref rid="B28" ref-type="bibr">28</xref>). There are few reports about the prevalence of <italic>bla</italic><sub>CTXM-15</sub> among diarrheagenic <italic>E. coli</italic>. In a study conducted by Memariani et al in Tehran, the <italic>bla</italic><sub>CTXM-15</sub> variant was identified in all of the <italic>bla</italic><sub>CTXM-1</sub> positive EPEC isolates (<xref rid="B11" ref-type="bibr">11</xref>). In our study, most of the strains produced <italic>bla</italic><sub>CTX-M-15</sub>. The <italic>bla</italic><sub>CTX-M-15</sub> is sometimes associated with other genes, such as <italic>bla</italic><sub>TEM-1</sub>. In a study conducted by Natarajan et al in India, the prevalence rates of <italic>bla</italic><sub>CTX-M</sub><sub>, </sub><italic>bla</italic><sub>TEM</sub>, and <italic>bla</italic><sub>SHV</sub> in EIEC isolates were (33.3%), (33.3%), and (0%) respectively (<xref rid="B24" ref-type="bibr">24</xref>). Zhou et al. in China reported that (50%) of EIEC strains among children under 5 years old were positive for <italic>bla</italic><sub>TEM-1</sub> (<xref rid="B29" ref-type="bibr">29</xref>). In our study, the <italic>bla</italic><sub>CTX-M-15</sub>gene was found to coexist with <italic>bla</italic><sub>TEM-1</sub> and <italic>bla</italic><sub>CTX-M-1</sub> genes in four isolates. In the present study, resistance to third-generation cephalosporins was most associated with the CTX-M-1 group. </p><p>None of the isolates had <italic>bla</italic><sub>SHV</sub>. Neither <italic>bla</italic><sub>KPC</sub> nor <italic>bla</italic><sub>GES</sub> genes were found in this study. However, the results of MHT revealed that all imipenem-resistant isolates were positive for carbapenemase production. In spite of a significant increase in the resistance of carbapenem strains in Iran, our findings showed that probably, other carbapenem genes such as IMI, OXA, and IMP cause resistance to carbapenems.</p><p>The genetic diversity of ESBLs producing EIEC isolates has not been studied until now. This is the first report on the evaluation of MLVA for genotyping of class A ESBL genes-harboring EIEC strains. MLVA has been successfully used for genotyping ESBL produces <italic>E. coli</italic> in Denmark (<xref rid="B30" ref-type="bibr">30</xref>). In the current study, all ESBLs producing EIEC isolates were discriminated into six different MLVA types with two clusters. The analysis of the UPGMA cluster showed that there is a high genetic diversity in EIEC strains harboring &#x003b2;-lactamase genes. CTX-M-15 gene was the most prevalent &#x003b2;-lactamase among the ESBLs positive EIEC isolates. The presence of the ESBLs genes in unrelated isolates might be because of the horizontal dissemination of mobile genetic elements in the unrelated isolates. This gave us a vision of the current prevalence and the genetic diversity among ESBLs producing strains of EIEC. In our study, EIEC strains with similar MLVA patterns had similar ESBLs gene profiles and similar antibiotic resistance patterns (strains 3 and 5). However, in some cases, EIEC strains with different MLVA types had similar ESBLs gene profiles (strains 4, 2, and 7). The presence of isolates with similar patterns indicates that clonal spread is also involved in the dissemination of ESBL-producing isolates. This study showed that MLVA is an appropriate typing method for epidemiological studies of <italic>E. coli</italic> species due to rapidity, technical simplicity, and the ability to generate numerical data which can be easily shared among medical laboratories. The use of MLVA for typing ESBL <italic>E. coli</italic> remains limited, with some research published and the lack of a shared database for researchers is a disadvantage.</p><p>The current study suggests that EIEC may be an important and unrecognized cause of acute diarrhea in children. Thus, use of the molecular diagnostic methods for detecting EIEC and appropriate treatment can be helpful. Also, molecular epidemiologic studies play a significant role in evaluating transmission ways of the pathogen for infection control. Our investigation revealed the widespread prevalence of multidrug-resistant and ESBL-producing EIEC isolates in Ahvaz. These results indicate that it is necessary to continuously monitor the emergence and spread of ESBL-producing isolates for the use of efficient antimicrobials in clinical practice.</p></sec></body><back><ack><title>Acknowledgment</title><p>Our appreciation goes to the Vice of Chancellor for Research Affairs, and Tropical and Infectious Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran for their financial and executive support (Grant No.B-9643).</p></ack><sec><title>Conflict of interests</title><p>The authors declare that they have no conflict of interest.</p></sec><ref-list><title>References</title><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jadali</surname><given-names>F</given-names></name><name><surname>Karimi</surname><given-names>Ab</given-names></name><name><surname>Fallah</surname><given-names>F</given-names></name><name><surname>Zahraei</surname><given-names>M</given-names></name><name><surname>Esteghamati</surname><given-names>A</given-names></name><name><surname>Navidinia</surname><given-names>M</given-names></name><etal/></person-group><article-title>A survey on rotavirus associated diarrhea in 5 main cities of Iran</article-title><source> Arch Pediatr Infect Dis</source><year>2013</year><volume>1</volume><fpage>23</fpage><lpage>6</lpage></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>A</given-names></name><name><surname>Giugliano</surname><given-names>L</given-names></name></person-group><article-title>Adhesion of diarrheagenic Escherichia coli and inhibition by glycocompounds engaged in the mucosal innate immunity</article-title><source> Biology</source><year>2013</year><volume>2</volume><fpage>810</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">24832810</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abbasi</surname><given-names>P</given-names></name><name><surname>Kargar</surname><given-names>M</given-names></name><name><surname>Doosti</surname><given-names>A</given-names></name><name><surname>Mardaneh</surname><given-names>J</given-names></name><name><surname>Dalini</surname><given-names>SG</given-names></name><name><surname>Dehyadegari</surname><given-names>MA</given-names></name></person-group><article-title>Real time pcr for characterization of enteroinvasive e Coli (eiec) in children with diarrhea in shiraz</article-title><source> Ann Colorectal Res</source><year>2014</year><volume>2</volume><fpage>e22721</fpage></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hosseini</surname><given-names>Nave H</given-names></name><name><surname>Mansouri</surname><given-names>S</given-names></name><name><surname>Moghadam</surname><given-names>MT</given-names></name><name><surname>Moradi</surname><given-names>M</given-names></name></person-group><article-title>Virulence gene profile and multilocus variable-number tandem-repeat analysis (MLVA) of enteroinvasive Escherichia coli (EIEC) isolates from patients with diarrhea in Kerman, Iran</article-title><source> Jundishapur J Microbiol</source><year>2016</year><volume>9</volume><fpage>e33529</fpage><pub-id pub-id-type="pmid">27635212</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>T</given-names></name><name><surname>Toma</surname><given-names>C</given-names></name><name><surname>Nakasone</surname><given-names>N</given-names></name><name><surname>Iwanaga</surname><given-names>M</given-names></name></person-group><article-title>Sensitive and rapid detection of Shigella and enteroinvasive Escherichia coli by a loop-mediated isothermal amplification method</article-title><source> FEMS Microbiol Lett</source><year>2005</year><volume>243</volume><fpage>259</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">15668027</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowe</surname><given-names>CF</given-names></name><name><surname>Katz</surname><given-names>K</given-names></name><name><surname>McGeer</surname><given-names>AJ</given-names></name><name><surname>Muller</surname><given-names>MP</given-names></name><name><surname>Group</surname><given-names>TEW</given-names></name></person-group><article-title>Efficacy of admission screening for extended-spectrum beta-lactamase producing Enterobacteriaceae</article-title><source> PLoS One</source><year>2013</year><volume>8</volume><fpage>e62678</fpage><pub-id pub-id-type="pmid">23638132</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>SF</given-names></name><name><surname>Ali</surname><given-names>MMM</given-names></name><name><surname>Mohamed</surname><given-names>ZK</given-names></name><name><surname>Moussa</surname><given-names>TA</given-names></name><name><surname>Klena</surname><given-names>JD</given-names></name></person-group><article-title>Fecal carriage of extended-spectrum &#x003b2;-lactamases and AmpC-producing Escherichia coli in a Libyan community</article-title><source> Ann Clin Microbiol Antimicrob</source><year>2014</year><volume>13</volume><fpage>22</fpage><pub-id pub-id-type="pmid">24934873</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sonnevend</surname><given-names>A</given-names></name><name><surname>Ghazawi</surname><given-names>A</given-names></name><name><surname>Alqahtani</surname><given-names>M</given-names></name><name><surname>Shibl</surname><given-names>A</given-names></name><name><surname>Jamal</surname><given-names>W</given-names></name><name><surname>Hashmey</surname><given-names>R</given-names></name><etal/></person-group><article-title>Plasmid-mediated colistin resistance in Escherichia coli from the Arabian Peninsula</article-title><source> Int J Infect Dis</source><year>2016</year><volume>50</volume><fpage>85</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">27566913</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeon</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>K</given-names></name><name><surname>Karim</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>C-R</given-names></name><etal/></person-group><article-title>Structural basis for carbapenem-hydrolyzing mechanisms of carbapenemases conferring antibiotic resistance</article-title><source> Int J Mol Sci</source><year>2015</year><volume>16</volume><fpage>9654</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">25938965</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Derakhshan</surname><given-names>S</given-names></name><name><surname>Peerayeh</surname><given-names>SN</given-names></name><name><surname>Bakhshi</surname><given-names>B</given-names></name></person-group><article-title>Genotyping and characterization of CTX-M-15-producing Klebsiella pneumoniae isolated from an Iranian hospital</article-title><source> J Chemother</source><year>2016</year><volume>28</volume><fpage>289</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">25734924</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Memariani</surname><given-names>M</given-names></name><name><surname>Peerayeh</surname><given-names>SN</given-names></name><name><surname>Salehi</surname><given-names>TZ</given-names></name><name><surname>Mostafavi</surname><given-names>SKS</given-names></name></person-group><article-title>The occurrence of SHV, TEM and CTX-M &#x003b2;-lactamase genes among enteropathogenic Escherichia coli strains isolated from children with diarrhea</article-title><source> Jundishapur J Microbiol</source><year>2015</year><volume>8</volume><fpage>e15620</fpage><pub-id pub-id-type="pmid">26034531</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ranjbar</surname><given-names>R</given-names></name><name><surname>Memariani</surname><given-names>M</given-names></name></person-group><article-title>Multilocus variable-number tandem-repeat analysis for genotyping of Shigella sonnei strains isolated from pediatric patients</article-title><source> Gastroenterol Hepatol Bed Bench</source><year>2015</year><volume>8</volume><fpage>225</fpage><pub-id pub-id-type="pmid">26328045</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="book"><collab>CLSI</collab><source>M100-S28. Performance Standards for Antimicrobial Susceptibility Testing. Twenty-eight informational supplement M100</source><year>2018</year><publisher-loc>Wayne</publisher-loc><publisher-name>Clinical and Laboratory Standards Institute</publisher-name></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magiorakos</surname><given-names>AP</given-names></name><name><surname>Srinivasan</surname><given-names>A</given-names></name><name><surname>Carey</surname><given-names>R</given-names></name><name><surname>Carmeli</surname><given-names>Y</given-names></name><name><surname>Falagas</surname><given-names>M</given-names></name><name><surname>Giske</surname><given-names>C</given-names></name><etal/></person-group><article-title>Multidrug&#x02010;resistant, extensively drug&#x02010;resistant and pandrug&#x02010;resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance</article-title><source> Clin Microbiol Infect</source><year>2012</year><volume>18</volume><fpage>268</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">21793988</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peerayeh</surname><given-names>SN</given-names></name><name><surname>Rostami</surname><given-names>E</given-names></name><name><surname>Siadat</surname><given-names>SD</given-names></name><name><surname>Derakhshan</surname><given-names>S</given-names></name></person-group><article-title>High rate of aminoglycoside resistance in CTX-M-15 producing Klebsiella pneumoniae isolates in Tehran, Iran</article-title><source> Lab Med</source><year>2014</year><volume>45</volume><fpage>231</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">25051075</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Latifpour</surname><given-names>M</given-names></name><name><surname>Gholipour</surname><given-names>A</given-names></name><name><surname>Damavandi</surname><given-names>MS</given-names></name></person-group><article-title>Prevalence of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates in nosocomial and community-acquired urinary tract infections</article-title><source> Jundishapur J Microbiol</source><year>2016</year><volume>9</volume><fpage>e31179</fpage><pub-id pub-id-type="pmid">27226874</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sedighi</surname><given-names>M</given-names></name><name><surname>Halajzadeh</surname><given-names>M</given-names></name><name><surname>Ramazanzadeh</surname><given-names>R</given-names></name><name><surname>Amirmozafari</surname><given-names>N</given-names></name><name><surname>Heidary</surname><given-names>M</given-names></name><name><surname>Pirouzi</surname><given-names>S</given-names></name></person-group><article-title>Molecular detection of &#x003b2;-lactamase and integron genes in clinical strains of Klebsiella pneumoniae by a multiplex polymerase chain reaction</article-title><source> Rev Soc Bras Med Trop</source><year>2017</year><volume>50</volume><fpage>321</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">28700049</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gorg&#x000e9;</surname><given-names>O</given-names></name><name><surname>Lopez</surname><given-names>S</given-names></name><name><surname>Hilaire</surname><given-names>V</given-names></name><name><surname>Lisanti</surname><given-names>O</given-names></name><name><surname>Ramisse</surname><given-names>V</given-names></name><name><surname>Vergnaud</surname><given-names>G</given-names></name></person-group><article-title>Selection and validation of a multilocus variable-number tandem-repeat analysis panel for typing Shigella spp</article-title><source> JCM</source><year>2008</year><volume>46</volume><fpage>1026</fpage><lpage>36</lpage></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weniger</surname><given-names>T</given-names></name><name><surname>Krawczyk</surname><given-names>J</given-names></name><name><surname>Supply</surname><given-names>P</given-names></name><name><surname>Niemann</surname><given-names>S</given-names></name><name><surname>Harmsen</surname><given-names>D</given-names></name></person-group><article-title>MIRU-VNTR plus: a web tool for polyphasic genotyping of Mycobacterium tuberculosis complex bacteria</article-title><source> Nucleic Acids Res</source><year>2010</year><volume>38</volume><fpage>W326</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">20457747</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moshtagian</surname><given-names>F</given-names></name><name><surname>Alipour</surname><given-names>M</given-names></name><name><surname>Yahyapour</surname><given-names>Y</given-names></name></person-group><article-title>Prevalence of Escherichia coli Pathotypes Among Children With Diarrhea in Babol, Northern Iran</article-title><source> Int J Enteric Pathog</source><year>2016</year><volume>4</volume><fpage>1</fpage><lpage>4</lpage></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alizade</surname><given-names>H</given-names></name><name><surname>Ghanbarpour</surname><given-names>R</given-names></name><name><surname>Aflatoonian</surname><given-names>MR</given-names></name></person-group><article-title>Molecular study on diarrheagenic Escherichia coli pathotypes isolated from under 5 years old children in the southeast of Iran</article-title><source> Asian Pac J Trop</source><year>2014</year><volume>4</volume><fpage>S813</fpage><lpage>7</lpage></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chellapandi</surname><given-names>K</given-names></name><name><surname>Dutta</surname><given-names>TK</given-names></name><name><surname>Sharma</surname><given-names>I</given-names></name><name><surname>De</surname><given-names>Mandal S</given-names></name><name><surname>Kumar</surname><given-names>NS</given-names></name><name><surname>Ralte</surname><given-names>L</given-names></name></person-group><article-title>Prevalence of multi drug resistant enteropathogenic and enteroinvasive Escherichia coli isolated from children with and without diarrhea in Northeast Indian population</article-title><source> Ann Clin Microbiol Antimicrob</source><year>2017</year><volume>16</volume><fpage>49</fpage><pub-id pub-id-type="pmid">28693504</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broujerdi</surname><given-names>SM</given-names></name><name><surname>Ardakani</surname><given-names>MR</given-names></name><name><surname>Rezatofighi</surname><given-names>SE</given-names></name></person-group><article-title>Characterization of diarrheagenic Escherichia coli strains associated with diarrhea in children, Khouzestan, Iran</article-title><source> J Infect Dev Ctries</source><year>2018</year><volume>12</volume><fpage>649</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">31958328</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Natarajan</surname><given-names>M</given-names></name><name><surname>Kumar</surname><given-names>D</given-names></name><name><surname>Mandal</surname><given-names>J</given-names></name><name><surname>Biswal</surname><given-names>N</given-names></name><name><surname>Stephen</surname><given-names>S</given-names></name></person-group><article-title>A study of virulence and antimicrobial resistance pattern in diarrhoeagenic Escherichia coli isolated from diarrhoeal stool specimens from children and adults in a tertiary hospital, Puducherry, India</article-title><source> J Health Popul Nutr</source><year>2018</year><volume>37</volume><fpage>17</fpage><pub-id pub-id-type="pmid">30005599</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quan-Cheng</surname><given-names>K</given-names></name><name><surname>Jian-Guo</surname><given-names>W</given-names></name><name><surname>Xiang-Hua</surname><given-names>L</given-names></name><name><surname>Zhen-Zhen</surname><given-names>L</given-names></name></person-group><article-title>Inappropriate use of antibiotics in children in China</article-title><source> Lancet</source><year>2016</year><volume>387</volume><fpage>1273</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">27025429</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aminshahidi</surname><given-names>M</given-names></name><name><surname>Arastehfar</surname><given-names>A</given-names></name><name><surname>Pouladfar</surname><given-names>G</given-names></name><name><surname>Arman</surname><given-names>E</given-names></name><name><surname>Fani</surname><given-names>F</given-names></name></person-group><article-title>Diarrheagenic Escherichia coli and Shigella with high rate of extended-spectrum Beta-lactamase production: two predominant etiological agents of acute diarrhea in Shiraz, Iran</article-title><source> Microb Drug Resist</source><year>2017</year><volume>23</volume><fpage>1037</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">29106325</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navidinia</surname><given-names>M</given-names></name><name><surname>Najar-Peerayeh</surname><given-names>S</given-names></name><name><surname>Fallah</surname><given-names>F</given-names></name><name><surname>Bakhshi</surname><given-names>B</given-names></name><name><surname>Adabian</surname><given-names>S</given-names></name><name><surname>Alimehr</surname><given-names>Sh</given-names></name><name><surname>Gholinejad</surname><given-names>Z</given-names></name></person-group><article-title>Distribution of pathogenicity islands markers (PAIs) in uropathogenic Escherichia coli isolated from children in Mofid Children Hospital</article-title><source> Arch Pediatr Infect Dis</source><year>2013</year><volume>1</volume><fpage>75</fpage><lpage>9</lpage></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pitout</surname><given-names>JD</given-names></name><name><surname>Laupland</surname><given-names>KB</given-names></name></person-group><article-title>Extended-spectrum &#x003b2;-lactamase-producing Enterobacteriaceae: an emerging public-health concern</article-title><source> Lancet Infect Dis</source><year>2008</year><volume>8</volume><fpage>159</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">18291338</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Hou</surname><given-names>H</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Mao</surname><given-names>L</given-names></name><etal/></person-group><article-title>Characteristics of diarrheagenic Escherichia coli among children under 5 years of age with acute diarrhea: a hospital based study</article-title><source> BMC Infect Dis</source><year>2018</year><volume>18</volume><fpage>63</fpage><pub-id pub-id-type="pmid">29390982</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nielsen</surname><given-names>J</given-names></name><name><surname>Albayati</surname><given-names>A</given-names></name><name><surname>J&#x000f8;rgensen</surname><given-names>RL</given-names></name><name><surname>Hansen</surname><given-names>K</given-names></name><name><surname>Lundgren</surname><given-names>B</given-names></name><name><surname>Sch&#x000f8;nning</surname><given-names>K</given-names></name></person-group><article-title>An abbreviated MLVA identifies Escherichia coli ST131 as the major extended-spectrum &#x003b2;-lactamase-producing lineage in the Copenhagen area</article-title><source> Eur J Clin Microbiol Infect Dis</source><year>2013</year><volume>32</volume><fpage>431</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">23129461</pub-id></element-citation></ref></ref-list></back></article>